Evogene (EVGN) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q2 EPS of ($0.13), $0.15 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $350 thousand versus the consensus estimate of $325 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
- Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
